| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |